Phase 2 trial of bezisterim in newly diagnosed patients to start soon - Parkinson's News Today
BioVie expects to launch the trial, assessing its oral therapy as a first and stand-alone treatment, in the opening months of 2025.
Search Group
Share To
Comments
About Screade
Screade® Inc. version 1.0, copyright 2016 - 2024
Blocked Users
Customize Dark Theme
Forgot your password?
Forgot your password?
Invite your friends
Please type emails of people you want to invite, we will send them invitation email on your behalf. Separate emails with comma if you want to invite multiple friends.
Comments